Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer
This study has been completed.
Study NCT00140400
Information provided by Cell Genesys
First Received on August 30, 2005.
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
